Contact  |  Site Map  |  Wison Group  |  Zerun  |  中文版

Founded in December 2007, Genor Biopharma Co. Ltd. is an innovation-driven biopharmaceutical company focused on development and commercialization of therapeutic monoclonal antibodies (mAbs), Fc-fusion proteins and recombinant therapeutic proteins.

With accumulated investment of 20 million dollar from Wison group, Genor now has more than 50 employees and possesses 1000 m2 of R&D center, and 1000 m2 of quality control center.